Spectral analysis applied to hepatobiliary dynamic scintigraphy with 99Tcm-n-pyridoxyl-5-methyltryptophan

Nuclear Medicine Communications

Volumn 18, Issue 11, 1997, Pages 1049-1056

  Murase, K ^a   Tsuda, T ^a   Tanada, S ^a   Ikezoe, J ^a   Mochizuki, T ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ehime Imabari Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYL N PYRIDOXYLTRYPTOPHAN TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; FEMALE; HEPATOBILIARY SCINTISCANNING; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN RESIDENCE TIME; SPECTROSCOPY;

EID: 0030842330     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199711000-00008     Document Type: Article

References (17)

1. Kato-Azuma M. Tc-99m (Sn)-N-pyridoxylaminatos: A new series of hepatobiliary imaging agents. J Nucl Med 1982; 23: 517-524.
2. Tsuda T. Clinical evaluation of kinetic model for the quantification of liver function with Tc-99m PMT and dynamic scintigraphy. Nippon Acta Rudiologiai 1994; 54: 1030-1040.
3. Pors Nielson S, Trap-Jensen J, Lindenberg J et al. Hepatobiliary scintigraphy and hepatography with Tc-99m di- ethyl-acetanilido-iminodiacetate in obstructive jaundice. J Nucl Med 1978; 19: 452-457.
4. Reichelt HG, Popescu HI. The importance of liver uptake and retention indices in assessment of clinical usefulness of hepatobiliary imaging agents. J Nucl Med 1979; 20: 171-172.
5. Tarolo GL, Picozzi R, Palagi B et al. Comparative quantitative evaluation of hepatic clearance of diethyl-IDA and para-butyl-IDA in jaundiced and nonjaundiced patients. Eur J Nucl Med 1981; 6: 539-543.
6. Brown PH, Juni JE, Lieberman DA, Krishna murthy GT. Hepatocyte versus biliary disease: A distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med 1988; 29: 623-630.
7. Gambhir SS, Hawkins RA, Huang S-C, Hall TR, Busuttil RW, Phelps ME. Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. J Nucl Med 1989;30: 1507-1518.
8. Howman-Giles R, Moase A, Gaskin K, Uren R. Hepatobiliary scintigraphy in a pediatric population: Determination of hepatic extraction fraction by deconvolution analysis. J Nucl Med 1993; 34: 214-221.
9. Cunningham VJ, Jones T. Spectal analysis of dynamic PET studies. J Cercb Blood Flow Metnb 1993; 13: 15-23.
10. Lawson CL, Hanson RJ. In: Solving least squares problems. Englewood Cliffs, NJ: Prentice-Hall, 1974.
11. Araikum S, Mdaka T, Esser JD, Zuckerman M. Hepatobiliary kinetics of technetium-99m-IDA analogs: Quantification by linear systems theory. J Nucl Med 1996; 37: 1323-1330.
12. Beck JV, Arnold KJ. In: Parameter estimation in engineering and science. New York: John Wiley, 1977.
13. Juni JE, Thrall JH, Froelich JW, Wiggins RC, Campbell DA, Tuscan M. The appended curvae technique for deconvolutional analysis - method and validation. Eur j Nucl Med 1988; 14: 403-407.
14. Tsuda T, Murase K, Tanada S, Ikezoe J. Clinical evaluation of spectral analysis for the quantification of chronic liver diseases with Tc-99m PMT and dynamic scintigraphy (abstract). J Nucl Med 1997; 38: 253-254P.
15. Leevy CH, Mandenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin invest 1962; 41: 1169-1179.
16. O’Reilly PH, Shields RA, Testa HJ. In: Nuclear medicine in urology and nephrology. London: Butterworths, 1979: 168-181.
17. Rutland MD. A single injection technique for subtraction of blood background in niI-hippuran renograms. Br J Radiol 1979; 52: 134-137.